Exact Mass: 379.06919880000004

Exact Mass Matches: 379.06919880000004

Found 28 metabolites which its exact mass value is equals to given mass value 379.06919880000004, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

   

Griseolic acid

5-(6-amino-9H-purin-9-yl)-2-[carboxy(hydroxy)methyl]-6-hydroxy-2H,5H,6H,6aH-furo[3,2-b]furan-2-carboxylic acid

C14H13N5O8 (379.0764098)


   

Methyl 2-(2-acetoxy-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)-2-(2-chlorophenyl)acetate

Methyl 2-[2-(acetyloxy)-4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl]-2-(2-chlorophenyl)acetic acid

C18H18ClNO4S (379.0645018000001)


   

Dimethane sulfonate

2-[(4-Formyl-3-methylphenyl)[2-(methanesulphonyloxy)ethyl]amino]ethyl methanesulphonic acid

C14H21NO7S2 (379.0759396)


   

N-(p-Toluenesulfonyl)-L-phenylalanyl Chloromethyl Ketone

N-(5-Chloro-3,4-dioxo-1-phenylpentan-2-yl)-4-methylbenzene-1-sulphonamide

C18H18ClNO4S (379.0645018000001)


   
   

3-(2,3-Dihydro-1H-indol-1-yl)-2-{[5-(trifluoromethyl)-2-pyridyl]sulfonyl}acrylonitrile

3-(2,3-Dihydro-1H-indol-1-yl)-2-{[5-(trifluoromethyl)-2-pyridyl]sulfonyl}acrylonitrile

C17H12F3N3O2S (379.0602288)


   
   
   

4-[(2E)-2-(8-oxoquinolin-5-ylidene)hydrazinyl]naphthalene-1-sulfonic acid

4-[(2E)-2-(8-oxoquinolin-5-ylidene)hydrazinyl]naphthalene-1-sulfonic acid

C19H13N3O4S (379.0626738000001)


   

4-(3-(2,5-DIFLUOROPHENYL)-5,5-DIMETHYL-4-OXO-4,5-DIHYDROFURAN-2-YL)BENZENESULFONAMIDE

4-(3-(2,5-DIFLUOROPHENYL)-5,5-DIMETHYL-4-OXO-4,5-DIHYDROFURAN-2-YL)BENZENESULFONAMIDE

C18H15F2NO4S (379.0689814000001)


   
   

Dimethane sulfonate

Dimethane sulfonate

C14H21NO7S2 (379.0759396)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent

   

Methyl 2-(2-acetoxy-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)-2-(2-chlorophenyl)acetate

Methyl 2-(2-acetoxy-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)-2-(2-chlorophenyl)acetate

C18H18ClNO4S (379.0645018000001)


   
   

2-(4-chlorophenyl)-N-[4-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]phenyl]acetamide

2-(4-chlorophenyl)-N-[4-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]phenyl]acetamide

C20H14ClN3O3 (379.0723644000001)


   

4-Cyanobenzoic acid [6-[[(4-methyl-2-pyrimidinyl)thio]methyl]-4-oxo-3-pyranyl] ester

4-Cyanobenzoic acid [6-[[(4-methyl-2-pyrimidinyl)thio]methyl]-4-oxo-3-pyranyl] ester

C19H13N3O4S (379.0626738000001)


   

6-(4-fluoro-1,3-benzodioxol-5-yl)-N-(thiophen-2-ylmethyl)-4-quinazolinamine

6-(4-fluoro-1,3-benzodioxol-5-yl)-N-(thiophen-2-ylmethyl)-4-quinazolinamine

C20H14FN3O2S (379.0790716)


   

[[2-[5-(2-Chlorophenyl)-1-tetrazolyl]-6,8-dioxabicyclo[3.2.1]octan-4-ylidene]amino]thiourea

[[2-[5-(2-Chlorophenyl)-1-tetrazolyl]-6,8-dioxabicyclo[3.2.1]octan-4-ylidene]amino]thiourea

C14H14ClN7O2S (379.0618174)


   

2-(4-chlorophenoxy)-N-(2-pyridin-4-yl-1,3-benzoxazol-5-yl)acetamide

2-(4-chlorophenoxy)-N-(2-pyridin-4-yl-1,3-benzoxazol-5-yl)acetamide

C20H14ClN3O3 (379.0723644000001)


   

[4-[(E)-(pyridine-2-carbonylhydrazinylidene)methyl]phenyl] 2-chlorobenzoate

[4-[(E)-(pyridine-2-carbonylhydrazinylidene)methyl]phenyl] 2-chlorobenzoate

C20H14ClN3O3 (379.0723644000001)


   

[(3R,4S,5R,6R)-3,5-dihydroxy-6-(hydroxymethyl)-4-phosphonooxyoxan-2-yl] 2-aminobenzoate

[(3R,4S,5R,6R)-3,5-dihydroxy-6-(hydroxymethyl)-4-phosphonooxyoxan-2-yl] 2-aminobenzoate

C13H18NO10P (379.0668298)


   

2-(alpha-Furyl)-6-hydroxychromanone para-nitrobenzoate

2-(alpha-Furyl)-6-hydroxychromanone para-nitrobenzoate

C20H13NO7 (379.06919880000004)


   

5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)-1,3-benzothiazol-6-yl hydrogen sulfate

5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)-1,3-benzothiazol-6-yl hydrogen sulfate

C16H17N3O4S2 (379.0660442)


An aryl sulfate obtained by sulfation of the phenolic hydroxy group of the anti-inflammatory drug, E3040. It is one of the major metabolites of E3040.

   

Vicagrel

Vicagrel

C18H18ClNO4S (379.0645018000001)


Vicagrel is a potent, safe and orally active antiplatelet agent, which works by irreversibly inhibiting P2Y12 receptor. Vicagrel can be used for the research of blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease[1][2].